Hepatitis B vaccine and first episodes of central nervous system demyelinating disorders: a comparison between reported and expected number of cases.
作者信息
Fourrier A, Bégaud B, Alpérovitch A, Verdier-Taillefer M H, Touzé E, Decker N, Imbs J L
出版信息
Br J Clin Pharmacol. 2001 May;51(5):489-90. doi: 10.1046/j.1365-2125.2001.01364.x.
Abstract
摘要
相似文献
1
Hepatitis B vaccine and first episodes of central nervous system demyelinating disorders: a comparison between reported and expected number of cases.乙型肝炎疫苗与中枢神经系统脱髓鞘疾病的首发：报告病例数与预期病例数的比较
Br J Clin Pharmacol. 2001 May;51(5):489-90. doi: 10.1046/j.1365-2125.2001.01364.x.
2
[Pharmacovigilance of hepatitis B vaccines].
Bull Acad Natl Med. 2003;187(8):1489-98; discussion 1498-500.
3
Hepatitis B vaccination and first central nervous system demyelinating event: a case-control study.乙肝疫苗接种与首次中枢神经系统脱髓鞘事件：一项病例对照研究。
Neuroepidemiology. 2002 Jul-Aug;21(4):180-6. doi: 10.1159/000059520.
4
5
Hepatitis B vaccination and first central nervous system demyelinating events: reanalysis of a case-control study using the self-controlled case series method.乙型肝炎疫苗接种与首次中枢神经系统脱髓鞘事件：使用自我对照病例系列方法对一项病例对照研究的重新分析
Vaccine. 2007 Aug 1;25(31):5938-43. doi: 10.1016/j.vaccine.2007.05.032. Epub 2007 Jun 8.
6
Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.乙肝疫苗与儿童中枢神经系统炎性脱髓鞘疾病的风险
Neurology. 2009 Oct 27;73(17):1426-7. doi: 10.1212/WNL.0b013e3181bd1f7e.
7
Hepatitis B vaccine and central nervous system demyelinating diseases. Viral Hepatitis Prevention Board.
Pediatr Infect Dis J. 1999 Jan;18(1):23-4. doi: 10.1097/00006454-199901000-00007.
8
[Risk-benefit assessment of hepatitis B vaccination in France, 2006].[2006年法国乙肝疫苗接种的风险效益评估]
Rev Med Interne. 2006 Jan;27(1):40-5. doi: 10.1016/j.revmed.2005.06.001. Epub 2005 Jul 1.
9
[Sclerotic plaques and vaccination against hepatitis B].
Rev Neurol (Paris). 1998 Apr;154(3):205-7.
10
[Hepatitis B vaccine and demyelinating diseases: debate and disinformation].
Presse Med. 2009 Apr;38(4):519-23. doi: 10.1016/j.lpm.2009.01.002. Epub 2009 Feb 6.
引用本文的文献
1
The risk of acute disseminated encephalomyelitis (ADEM) following covid-19 vaccination in England: A self-controlled case-series analysis.英格兰新冠病毒疫苗接种后发生急性播散性脑脊髓炎（ADEM）的风险：一项自身对照病例系列分析。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2311969. doi: 10.1080/21645515.2024.2311969. Epub 2024 Feb 1.
2
Association between vaccination and the risk of central demyelination: results from a case-referent study.疫苗接种与中枢脱髓鞘风险的关联：病例对照研究的结果。
J Neurol. 2023 Oct;270(10):4678-4686. doi: 10.1007/s00415-023-11822-y. Epub 2023 Jun 23.
3
Hepatitis B Vaccine and Multiple Sclerosis: Cause or Coincidence.乙肝疫苗与多发性硬化症：因果关系还是巧合？
Cureus. 2022 Oct 5;14(10):e29941. doi: 10.7759/cureus.29941. eCollection 2022 Oct.
4
A rare presentation of undiagnosed multiple sclerosis after the COVID-19 vaccine.新冠疫苗接种后出现未确诊的多发性硬化症的罕见病例
J Community Hosp Intern Med Perspect. 2021 Nov 15;11(6):772-775. doi: 10.1080/20009666.2021.1979745. eCollection 2021.
5
Authors' Reply to Cohen et al.'s Comment on "Central Demyelinating Diseases after Vaccination Against Hepatitis B Virus: A Disproportionality Analysis within the VAERS Database".作者对科恩等人就《接种乙型肝炎病毒疫苗后中枢脱髓鞘疾病：疫苗不良事件报告系统数据库内的不成比例分析》的评论的回复
Drug Saf. 2018 Dec;41(12):1429-1430. doi: 10.1007/s40264-018-0734-3.
6
Central Demyelinating Diseases after Vaccination Against Hepatitis B Virus: A Disproportionality Analysis within the VAERS Database.接种乙型肝炎病毒疫苗后的中枢脱髓鞘疾病：VAERS 数据库中的比例失调分析。
Drug Saf. 2018 Aug;41(8):767-774. doi: 10.1007/s40264-018-0652-4.
7
Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?疫苗接种与自身免疫性疾病：预防对健康的不良影响在望吗？
EPMA J. 2017 Jul 20;8(3):295-311. doi: 10.1007/s13167-017-0101-y. eCollection 2017 Sep.
8
Vaccine Case-Population: A New Method for Vaccine Safety Surveillance.疫苗病例-人群：一种疫苗安全性监测的新方法。
Drug Saf. 2016 Dec;39(12):1197-1209. doi: 10.1007/s40264-016-0449-2.
9
Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.自乙肝疫苗接种开始以来法国多发性硬化症的演变情况。
Immunol Res. 2014 Dec;60(2-3):219-25. doi: 10.1007/s12026-014-8574-4.
10
Estimating time-to-onset of adverse drug reactions from spontaneous reporting databases.从自发报告数据库估算药物不良反应的发病时间。
BMC Med Res Methodol. 2014 Feb 3;14:17. doi: 10.1186/1471-2288-14-17.
本文引用的文献
1
Descriptive epidemiology of multiple sclerosis in Europe in the 1980s: a critical overview.20世纪80年代欧洲多发性硬化症的描述性流行病学：批判性综述。
Ann Neurol. 1994 Dec;36 Suppl 2:S164-74. doi: 10.1002/ana.410360803.
2
[Epidemiology of multiple sclerosis].[多发性硬化症的流行病学]
Rev Prat. 1991 Sep 15;41(20):1884-7.
Zotero 插件